The third form of supraventricular tachycardia (SVT) called atrial tachycardia is like a flashing light occurring from a place within the upper chambers. The electrical signal comes from this place and continues to spread throughout the upper heart chambers.
Treatment for atrial tachycardia usually uses the same anti-arrhythmic medications used to treat atrial fibrillation.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.